From the Courtroom to Capitol Hill: State Legislative Action on Failure-to-Warn Claims

Start
When a company brings a new product to market, who has the authority to approve the product’s label and associated warnings? In most instances involving pharmaceutical drugs or medical devices, it’s the federal Food and Drug Administration (FDA)….
By: Butler Snow LLP
Previous Story

Rule 45, Remote Testimony, and the Future of Subpoenas in Medical Device Litigation

Next Story

Memento Michigan Compiled Law § 600.2946(5): An Homage to Michigan’s Former Drug Immunity Law